MULTI-LINK VISION Coronary Stent System (International)

Discover a new world. See our Vision.

Abbott Vascular is recognized as a world leader in stent design and innovation. After 6 generations of success in stainless steel stent design, Abbott Vascular is leading again with ML VISION Coronary Stent System — the first in an entirely new class of cobalt chromium stents.

ML VISION Coronary Stent is laser-cut from a cobalt chromium superalloy that allows us to reduce strut thickness without compromising radial strength or radiopacity.

The result? Extraordinary deliverability, and the best clinical outcomes we’ve ever had.

Features

Specification

Features

Powered to Perform with Cobalt Chromium

see larger view

Thinner struts — for excellent clinical outcomes

The ML VISION Coronary Stent thin strut design — just .0032" thick — opens the path for an enlarged lumen, less vessel injury, and extraordinary clinical results.
In comparing stents with different strut thicknesses, the ISAR STEREO II clinical trial¹ concluded that thin strut design is associated with significantly lower restenosis rates and has a significant impact on clinical outcomes.

The best clinical data Abbott Vascular has ever had for a coronary stent!

VISION Registry 6–month clinical data highlights:

TLR² of 4.3%
Clinically driven TLR³ of 1.9%
MACE⁴ of 6.2%

^{1. ISAR STEREO II: Schühlen, H. et al. Presented at TCT 2002.

2. Target Lesion Revascularization (TLR; also called Target Site
Revascularization - TSR) measures clinical revascularization at the area within
and adjacent to the stent. TLR is defined as a repeat procedure at the original
lesion site any time during the follow-up period (one type of clinical
restenosis).

3. Clinically driven target lesion revascularization (TLR) provides an estimate
of the rate of TLR that might have been observed if angiographic follow-up had
not been required by the protocol. It is TLR due to > 50% DS (Diameter
Stenosis) with ischemic symptoms or positive functional study or due to >
70% DS without ischemic symptoms or positive functional study.

4. Major Adverse Cardiac Events}

Specification

MULTI-LINK VISION Part Numbers 170 KB

LT2922560

Printer Friendly